<VariationArchive VariationID="65611" VariationName="NM_000500.9(CYP21A2):c.923dup (p.Leu308fs)" VariationType="Duplication" Accession="VCV000065611" Version="18" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-07-23" DateCreated="2013-10-02" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="76519" VariationID="65611">
      <GeneList>
        <Gene Symbol="CYP21A2" FullName="cytochrome P450 family 21 subfamily A member 2" GeneID="1589" HGNC_ID="HGNC:2600" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32038415" stop="32041644" display_start="32038415" display_stop="32041644" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_113891.3" start="3476737" stop="3479966" display_start="3476737" display_stop="3479966" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167245.2" start="3279823" stop="3283052" display_start="3279823" display_stop="3283052" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3380452" stop="3383677" display_start="3380452" display_stop="3383677" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167249.2" start="3339605" stop="3342831" display_start="3339605" display_stop="3342831" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167248.2" start="3261650" stop="3264877" display_start="3261650" display_stop="3264877" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32006092" stop="32009446" display_start="32006092" display_stop="32009446" Strand="+" />
          </Location>
          <OMIM>613815</OMIM>
        </Gene>
        <Gene Symbol="LOC106780800" FullName="CYP21A2 recombination region" GeneID="106780800" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32037872" stop="32041144" display_start="32037872" display_stop="32041144" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3379909" stop="3383177" display_start="3379909" display_stop="3383177" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000500.9(CYP21A2):c.923dup (p.Leu308fs)</Name>
      <CanonicalSPDI>NC_000006.12:32040182:TTTTTTT:TTTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32040182" stop="32040183" display_start="32040182" display_stop="32040183" variantLength="1" positionVCF="32040182" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32007959" stop="32007960" display_start="32007959" display_stop="32007960" variantLength="1" positionVCF="32007959" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>L173fs</ProteinChange>
      <ProteinChange>L308fs</ProteinChange>
      <ProteinChange>L278fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.32007966dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.32007966dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.32040189dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.32040189dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007941.3" sequenceAccession="NG_007941" sequenceVersion="3" change="g.6885dup">
            <Expression>NG_007941.3:g.6885dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008337.2" sequenceAccession="NG_008337" sequenceVersion="2" change="g.74192dup">
            <Expression>NG_008337.2:g.74192dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_045215.1" sequenceAccession="NG_045215" sequenceVersion="1" change="g.2418dup">
            <Expression>NG_045215.1:g.2418dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.9" sequenceAccession="NM_000500" sequenceVersion="9" change="c.923dup" MANESelect="true">
            <Expression>NM_000500.9:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000491.4" sequenceAccession="NP_000491" sequenceVersion="4" change="p.Leu308fs">
            <Expression>NP_000491.4:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128590.4" sequenceAccession="NM_001128590" sequenceVersion="4" change="c.833dup">
            <Expression>NM_001128590.4:c.833dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001122062.3" sequenceAccession="NP_001122062" sequenceVersion="3" change="p.Leu278fs">
            <Expression>NP_001122062.3:p.Leu278fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368143.2" sequenceAccession="NM_001368143" sequenceVersion="2" change="c.518dup">
            <Expression>NM_001368143.2:c.518dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355072.1" sequenceAccession="NP_001355072" sequenceVersion="1" change="p.Leu173fs">
            <Expression>NP_001355072.1:p.Leu173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368144.2" sequenceAccession="NM_001368144" sequenceVersion="2" change="c.518dup">
            <Expression>NM_001368144.2:c.518dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355073.1" sequenceAccession="NP_001355073" sequenceVersion="1" change="p.Leu173fs">
            <Expression>NP_001355073.1:p.Leu173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_829" sequenceAccession="LRG_829">
            <Expression>LRG_829:g.6885dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_829t1" sequenceAccession="LRG_829t1">
            <Expression>LRG_829t1:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_829p1" sequenceAccession="LRG_829p1" change="p.Leu308fs">
            <Expression>LRG_829p1:p.Leu308fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.7" sequenceAccession="NM_000500" sequenceVersion="7" change="c.923dup">
            <Expression>NM_000500.7:c.923dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.9" sequenceAccession="NM_000500" sequenceVersion="9" change="c.923dupT" MANESelect="true">
            <Expression>NM_000500.9:c.923dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.7" sequenceAccession="NM_000500" sequenceVersion="7" change="c.923dupT">
            <Expression>NM_000500.7:c.923dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613815.0033" DB="OMIM" />
        <XRef Type="rs" ID="267606756" DB="dbSNP" />
        <XRef Type="Interpreted" ID="12182" DB="ClinVar" />
        <XRef ID="CA344934" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000500.9(CYP21A2):c.923dup (p.Leu308fs) AND Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" Accession="RCV000055821" Version="13">
        <ClassifiedConditionList TraitSetID="3295">
          <ClassifiedCondition DB="MedGen" ID="C2936858">Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-03-26" SubmissionCount="7">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000500.9(CYP21A2):c.923dup (p.Leu308fs) AND not provided" Accession="RCV000711389" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-13" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-26" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2013-10-02" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(10); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">10857554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11093272</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12915679</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16427797</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1644925</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16728546</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1869518</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19169499</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23359698</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2620669</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26804566</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27185867</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28275658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28392195</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28676275</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29035424</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29684512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30995443</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31446012</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35079965</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35094236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7635470</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301350</ID>
          <ID Source="BookShelf">NBK1171</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(10); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-04-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10963" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ElementValue>
                <XRef ID="MONDO:0008728" DB="MONDO" />
                <XRef ID="90794" DB="Orphanet" />
                <XRef ID="717261006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYP21 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia</ElementValue>
                <XRef ID="NBK1171" DB="GeneReviews" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">21-hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia (CAH), a family of autosomal recessive disorders involving impaired synthesis of cortisol from cholesterol by the adrenal cortex. In 21-OHD CAH, excessive adrenal androgen biosynthesis results in virilization in all individuals and salt wasting in some individuals. A classic form with severe enzyme deficiency and prenatal onset of virilization is distinguished from a non-classic form with mild enzyme deficiency and postnatal onset. The classic form is further divided into the simple virilizing form (~25% of affected individuals) and the salt-wasting form, in which aldosterone production is inadequate (â‰¥75% of individuals). Newborns with salt-wasting 21-OHD CAH are at risk for life-threatening salt-wasting crises. Individuals with the non-classic form of 21-OHD CAH present postnatally with signs of hyperandrogenism; females with the non-classic form are not virilized at birth.</Attribute>
                <XRef ID="NBK1171" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12665" />
                <XRef ID="12665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301350</ID>
                <ID Source="BookShelf">NBK1171</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2011">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/CAH.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Congenital Adrenal Hyperplasia, 2011</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Visio-NBS_Elevated_17OHP.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Congenital Adrenal Hyperplasia, 2009</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ESCGS, 2010">
                <ID Source="pmc">2936060</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2018">
                <ID Source="PubMed">30272171</ID>
                <ID Source="pmc">6456929</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/Elevated-17-OHP-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Congenital Adrenal Hyperplasia (Elevated 17-OHP), 2009</CitationText>
              </Citation>
              <XRef ID="90794" DB="Orphanet" />
              <XRef ID="C2936858" DB="MedGen" />
              <XRef ID="MONDO:0008728" DB="MONDO" />
              <XRef Type="MIM" ID="201910" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4124450" SubmissionDate="2022-04-01" DateLastUpdated="2022-04-02" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NVNT829|MedGen:C2936858" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002107077" DateUpdated="2022-04-02" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20301350</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2620669</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29035424</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19169499</ID>
          </Citation>
          <Comment>The c.923dupT;p.((Leu308Phefs*6) is a null frameshift variant (NMD) in the CYP21A2 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 65611; PMID: 20301350; PMID: 26206692; PMID: 29035424; PMID: 19169499) - PS4. The p.(Leu308Phefs*6) was detected in trans with a pathogenic variant (PMID: 29035424) - PM3. In summary, the currently available evidence indicates that the variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000500.9:exon 7</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="267606756" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2936858" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11164938</SubmissionName>
          <SubmissionName>SUB11265037</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4940812" SubmissionDate="2022-05-28" DateLastUpdated="2022-06-03" DateCreated="2022-06-03">
        <ClinVarSubmissionID localKey="6-32007959-G-GT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002521718" DateUpdated="2022-06-03" DateCreated="2022-06-03" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1644925</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.006%). However, frequency data for this variant in the general population cannot be distinguished from that of the (CYP21P) pseudogene, and are therefore uninformative in assessment of variant pathogenicity. Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000065611 / PMID: 1644925). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002902" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002153" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0031213" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008185" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201910" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11507599</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5452445" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000500.7:c.923dup|OMIM:201910" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002804022" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.7:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201910" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6128499" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4861265|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003439325" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10857554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1644925</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26804566</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28392195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30995443</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31446012</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu308Phefs*6) in the CYP21A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP21A2 are known to be pathogenic (PMID: 10857554). The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This premature translational stop signal has been observed in individual(s) with classic salt-wasting and simple virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency (PMID: 1644925, 26804566, 28392195, 30995443, 31446012). This variant is also known as F306+T. ClinVar contains an entry for this variant (Variation ID: 65611). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.32007959_32007960insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7183219" SubmissionDate="2023-03-16" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="NM_000500.7:c.923dupT|MedGen:C0852654" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003845011" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16427797</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1644925</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10857554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16728546</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7635470</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1869518</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28275658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27185867</ID>
          </Citation>
          <Comment>Variant summary: CYP21A2 c.923dupT (p.Leu308PhefsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 246362 control chromosomes. c.923dupT has been reported in the literature in multiple individuals affected with Congenital Adrenal Hyperplasia (de Carvalho_2016, Ezquieta_1995, Friaes_2006, Higashi_1991, Luczay_2006, Speiser_1992), and some of these individuals are reported with other (likely) pathogenic variants in trans. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on enzymatic activity, finding reduced activity when combined with a missense variant as compared to the missense variant alone or the wildtype construct (Khajuria_2018). Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and all laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.7:c.923dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0852654" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12956415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5426030" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="S9535|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002774383" DateUpdated="2024-01-06" DateCreated="2022-12-31" Type="SCV" Version="2" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28676275</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29684512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28392195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1644925</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26804566</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12915679</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11093272</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26206692</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23359698</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30995443</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31446012</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35094236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35079965</ID>
          </Citation>
          <Comment>The c.923dup pathogenic variant (also known as F306+1nt, F306+ T, and L307 frameshift) alters the translation reading frame of the CYP21A2 mRNA and causes the premature termination (p.Leu308Phefs*6) of CYP21A2 protein synthesis. This pathogenic variant is associated with salt-wasting CAH. Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.7:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12490872</SubmissionName>
          <SubmissionName>SUB14108248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1639984" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2018-10-20">
        <ClinVarSubmissionID localKey="A1799|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000841752" DateUpdated="2024-01-26" DateCreated="2018-10-20" Type="SCV" Version="3" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28676275</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29684512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28392195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1644925</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26804566</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12915679</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11093272</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26206692</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23359698</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30995443</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31446012</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35094236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35079965</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. Frequency data for this variant in the general population cannot be distinguished from that of the CYP21P pseudogene, and are therefore uninformative in assessment of variant pathogenicity. In multiple individuals with congenital adrenal hyperplasia, this variant has been seen in trans with other recessive pathogenic variants in CYP21A2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.7:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB14108777</SubmissionName>
          <SubmissionName>SUB4481681</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3962466" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="097d7df90b2ac063ca8953424e1f9a3ae012fd4fb3a2865676d55329c94752ae|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002018110" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8987789" SubmissionDate="2024-03-26" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_000500.9:c.923dup|OMIM:201910" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004807436" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201910" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14340590</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9874008" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000500_9_CYP21A2_c_923dupT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086883" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26804566</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35079965</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (MIM#201910) and hyperandrogenism nonclassic type due to 21-hydroxylase deficiency (MIM#201910). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous (according to Fulgent Genetics report). (I) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v3: 2 heterozygotes, 0 homozygotes). (SP) 0701 - Other variants predicted to result in NMD comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0801 - This variant has very strong previous evidence of pathogenicity in unrelated individuals. It has been detected in multiple compound heterozygous patients including as part of complex alleles harbouring multiple variants (ClinVar, LOVD, PMIDs: 35079965, 26804566). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21064</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201910" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145540" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-02" DateCreated="2013-10-02">
        <ClinVarSubmissionID localKey="NM_000500.5:c.923dupT(Leu307insT)_NBK1171" title="NM_000500.5:c.923dupT(Leu307insT) and 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia" />
        <ClinVarAccession Accession="SCV000086804" DateUpdated="2013-10-02" DateCreated="2013-10-02" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-08-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.5:c.923dupT(Leu307insT)</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1171" />
            <XRef DB="OMIM" ID="201910" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2863221" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-12" DateCreated="2020-12-12">
        <ClinVarSubmissionID localKey="NM_000500.9:c.923dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001450355" DateUpdated="2020-12-12" DateCreated="2020-12-12" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4940812" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002153" MappingRef="HP">
        <MedGen CUI="C0020461" Name="Hyperkalemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426030" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452445" TraitType="Disease" MappingType="XRef" MappingValue="201910" MappingRef="OMIM">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9874008" TraitType="Disease" MappingType="XRef" MappingValue="201910" MappingRef="OMIM">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940812" TraitType="Disease" MappingType="XRef" MappingValue="201910" MappingRef="OMIM">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940812" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008185" MappingRef="HP">
        <MedGen CUI="C1859979" Name="Precocious puberty in males" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940812" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002902" MappingRef="HP">
        <MedGen CUI="C0020625" Name="Hyponatremia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2863221" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8987789" TraitType="Disease" MappingType="XRef" MappingValue="201910" MappingRef="OMIM">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6128499" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145540" TraitType="Disease" MappingType="Name" MappingValue="21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia" MappingRef="Preferred">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4940812" TraitType="Finding" MappingType="XRef" MappingValue="HP:0031213" MappingRef="HP">
        <MedGen CUI="C4531273" Name="Elevated circulating 17-hydroxyprogesterone concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3962466" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4124450" TraitType="Disease" MappingType="XRef" MappingValue="C2936858" MappingRef="MedGen">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1639984" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7183219" TraitType="Disease" MappingType="XRef" MappingValue="C0852654" MappingRef="MedGen">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

